Newron wins discovery for potential suit over Parkinson's drug Xadago

Newron wins discovery for potential suit over Parkinson’s drug Xadago

Intellectual Property 2025-11-03 11:27 pm By Christine Caulfield

Please login to bookmark

Suspecting infringement of patents for its Parkinson’s drug, Xadago, biopharmaceutical company Newron has won preliminary discovery of documents from generic drug maker Arrotex Pharmaceuticals.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au